Advances in Stroke Prevention
Sanofi-Winthrop Symposium, Second European Stroke Conference, Lausanne, June 1992. "Cerebrovascular Diseases", Vol 3, Suppl. 1 (1993). Supplement Issue: Cerebrovascular Diseases 1993, Vol. 3, Suppl. 1
Published on 29. April 1993
Book
Paperback/Softback
IV, 44 pages
978-3-8055-5787-0 (ISBN)
Description
This publication summarizes of new information and presents concepts and data concerning stroke and its prevention. Topics discussed include: the pathogenesis of atherosclerosis, recognition of high-risk individuals with treatable risk factors, treatment and quality of life, advances in antiplatelet therapy and identification of cost-risk benefits. Focusing on the interrelationship between basic and clinical research, research applications and the cost and quality of life, this publication illustrates the true impact of stroke prevention and gives readers new perspectives concerning important clinical issues.
More details
Content
Gabbiani, G.: The Cytoskeleton of Arterial Smooth Muscle Cells during Human and Experimental Atheromatosis. Wolf, P.A.; Belanger, A.J.; D'Agostino, R.B.: Quantifying Stroke Risk Factors and Potentials for Risk Reduction. Easton J.D.: Update on Antiplatelet Therapy for Stroke Prevention. Wade, D.T.: Disability after Stroke and Its Impact on Secondary Prevention. Goldstein, M.:Stroke Prevention and Health Care Issues, An American Perspective. Asplund, K.; Marks, L.A .; Terent, A. et al.: Costs and Gains in Stroke Prevention, European Perspective. Dyken, M.: Concluding Remarks.